Annual report for Thyrocare Technologies Ltd. for FY-2021
10-05-2021
Thyrocare Technologies Ltd - 539871 - Outcome Of Board Meeting Held On 08-05-2021
This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the Audited Financial Results (Stand-alone and Consolidated) for the Financial Year ended March 31, 2021 and have also decided to recommend to the Shareholders for their approval, declaration of dividend at the rate of Rs. 15.00 (Rupees Fifteen only) per share (150% of the face value of Rs. 10/- each). Considering the interim dividend of Rs. 10/- already paid, the total dividend payout for FY 2020-21 would be Rs.25/- per share (250% of the face value of Rs.10/-)/08-05-2021
Thyrocare Technologies Ltd - 539871 - Outcome Of Board Meeting Held On 08-05-2021.
This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the Audited Financial Results (Stand-alone and Consolidated) for the Financial Year ended March 31, 2021 and have also decided to recommend to the Shareholders for their approval, declaration of dividend at the rate of Rs. 15.00 (Rupees Fifteen only) per share (150% of the face value of Rs. 10/- each). Considering the interim dividend of Rs. 10/- already paid, the total dividend payout for FY 2020-21 would be Rs.25/- per share (250% of the face value of Rs.10/-)/08-05-2021
Thyrocare Technologies Ltd - 539871 - Board to consider FY21 results & Final Dividend on May 08, 2021
Thyrocare Technologies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 08, 2021, inter alia, to consider and approve Audited Stand-alone and Consolidated Financial Results of the Company for the quarter / financial year ended March 31, 2021, to consider recommending final dividend, if any, for the financial year 2020-21, and to consider granting of Employee Stock Options for the financial year ended March 31, 2021.27-04-2021
Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Prior Intimation Under Regulation 29 (1) (A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Saturday, May 8, 2021, inter alia, to consider and approve Audited Stand-alone and Consolidated Financial Results of the Company for the quarter / financial year ended March 31, 2021, to consider recommending final dividend, if any, for the financial year 2020-21, and to consider granting of Employee Stock Options for the financial year ended March 31, 2021.27-04-2021
Thyrocare Technologies Ltd - 539871 - Compliance Certificate - Regulation No. 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate - Regulation No. 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201526-04-2021
Thyrocare Technologies Ltd - 539871 - Submission Of Compliance Certificate In Terms Of Regulation 40 (9) Of Securities & Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations, 2015
Submission of Compliance Certificate in terms of Regulation 40 (9) of Securities & Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 201524-04-2021
Thyrocare Technologies Ltd - 539871 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ramjee DoraiDesignation :- Company Secretary and Compliance Officer19-04-2021
Thyrocare Technologies Ltd - 539871 - Shareholding for the Period Ended March 31, 2021
Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here17-04-2021
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
Intimation of Resignation of Mr. Arindam Haldar as Chief Executive Officer08-04-2021